Diverse and targetable kinase alterations drive histiocytic neoplasms EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ... Cancer discovery 6 (2), 154-165, 2016 | 434 | 2016 |
Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome SHB Abina, HB Gaspar, J Blondeau, L Caccavelli, S Charrier, K Buckland, ... Jama 313 (15), 1550-1563, 2015 | 421 | 2015 |
Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 298 | 2017 |
BRAF mutation correlates with high-risk Langerhans cell histiocytosis and increased resistance to first-line therapy S Héritier, JF Emile, MA Barkaoui, C Thomas, S Fraitag, S Boudjemaa, ... Journal of clinical oncology 34 (25), 3023, 2016 | 298 | 2016 |
Vemurafenib for refractory multisystem Langerhans cell histiocytosis in children: an international observational study J Donadieu, IA Larabi, M Tardieu, J Visser, C Hutter, E Sieni, N Kabbara, ... Journal of Clinical Oncology 37 (31), 2857, 2019 | 158 | 2019 |
Inherited CARD9 Deficiency in 2 Unrelated Patients With Invasive Exophiala Infection F Lanternier, E Barbati, U Meinzer, L Liu, V Pedergnana, M Migaud, ... The Journal of Infectious Diseases 211 (8), 1241-1250, 2015 | 134 | 2015 |
Primary T-cell immunodeficiency with immunodysregulation caused by autosomal recessive LCK deficiency F Hauck, C Randriamampita, E Martin, S Gerart, N Lambert, A Lim, ... Journal of allergy and clinical immunology 130 (5), 1144-1152. e11, 2012 | 118 | 2012 |
Vemurafenib use in an infant for high-risk Langerhans cell histiocytosis S Héritier, M Jehanne, G Leverger, JF Emile, JC Alvarez, J Haroche, ... JAMA oncology 1 (6), 836-838, 2015 | 115 | 2015 |
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30‐year nationwide cohort of 1478 patients under 18 years of age C Rigaud, MA Barkaoui, C Thomas, Y Bertrand, A Lambilliotte, J Miron, ... British journal of haematology 174 (6), 887-898, 2016 | 107 | 2016 |
Prevalence and clinical impact of norovirus fecal shedding in children with inherited immune deficiencies P Frange, F Touzot, M Debré, S Héritier, M Leruez-Ville, G Cros, ... The Journal of infectious diseases 206 (8), 1269-1274, 2012 | 88 | 2012 |
Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey TA Briggs, GI Rice, N Adib, L Ades, S Barete, K Baskar, V Baudouin, ... Journal of clinical immunology 36, 220-234, 2016 | 78 | 2016 |
Spondyloenchondrodysplasia Due to Mutations in ACP5: A Comprehensive Survey TA Briggs, GI Rice, N Adib, L Ades, S Barete, K Baskar, V Baudouin, ... Journal of clinical immunology 36, 220-234, 2016 | 77 | 2016 |
Immune deficiency–related enteropathy-lymphocytopenia-alopecia syndrome results from tetratricopeptide repeat domain 7A deficiency R Lemoine, J Pachlopnik-Schmid, HF Farin, A Bigorgne, M Debré, ... Journal of allergy and clinical immunology 134 (6), 1354-1364. e6, 2014 | 75 | 2014 |
Circulating cell‐free BRAFV600E as a biomarker in children with Langerhans cell histiocytosis S Héritier, Z Hélias‐Rodzewicz, H Lapillonne, N Terrones, S Garrigou, ... British journal of haematology 178 (3), 457-467, 2017 | 74 | 2017 |
ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition PG Kemps, J Picarsic, BH Durham, Z Hélias-Rodzewicz, L Hiemcke-Jiwa, ... Blood, The Journal of the American Society of Hematology 139 (2), 256-280, 2022 | 68 | 2022 |
Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study S Héritier, MA Barkaoui, J Miron, C Thomas, D Moshous, A Lambilliotte, ... British journal of haematology 183 (4), 608-617, 2018 | 62 | 2018 |
Diverse and targetable kinase alterations drive histiocytic neoplasms. Cancer Discov 2016; 6: 154–65 doi: 10.1158/2159-8290 EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ... CD-15-0913.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 47 | |
New somatic BRAF splicing mutation in Langerhans cell histiocytosis S Héritier, Z Hélias-Rodzewicz, R Chakraborty, AG Sengal, ... Molecular Cancer 16, 1-5, 2017 | 41 | 2017 |
Common cancer-associated PIK3CA activating mutations rarely occur in Langerhans cell histiocytosis S Héritier, R Saffroy, N Radosevic-Robin, Y Pothin, H Pacquement, ... Blood, The Journal of the American Society of Hematology 125 (15), 2448-2449, 2015 | 36 | 2015 |
Highly sensitive methods are required to detect mutations in histiocytoses S Melloul, Z Hélias-Rodzewicz, F Cohen-Aubart, F Charlotte, S Fraitag, ... Haematologica 104 (3), e97, 2019 | 30 | 2019 |